Novel vasocontractile role of the P2Y14receptor: characterization of its signalling in porcine isolated pancreatic arteries

The Concise Guide to PHARMACOLOGY 2013/14: Overview

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

The UDP-sugar-sensing P2Y14 receptor promotes Rho-mediated signaling and chemotaxis in human neutrophils

(2012) Juliana I. Sesma et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Purinergic signalling in the pancreas in health and disease

(2012) G Burnstock et al.   JOURNAL OF ENDOCRINOLOGY

Signalling and pharmacological properties of the P2Y14 receptor

(2010) T. K. Harden et al.   Acta Physiologica

P2Y1 and P2Y13 purinergic receptors mediate Ca2+ signaling and proliferative responses in pulmonary artery vasa vasorum endothelial cells

(2010) Taras Lyubchenko et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Applying the pro-drug approach to afford highly bioavailable antagonists of P2Y14

(2010) Joël Robichaud et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Ca2+ signalling by P2Y receptors in cultured rat aortic smooth muscle cells

(2010) Sriram Govindan et al.   BRITISH JOURNAL OF PHARMACOLOGY

UDP-glucose acting at P2Y 14 receptors is a mediator of mast cell degranulation

(2009) Zhan-Guo Gao et al.   BIOCHEMICAL PHARMACOLOGY

Molecular recognition in the P2Y14 receptor: Probing the structurally permissive terminal sugar moiety of uridine-5′-diphosphoglucose

(2009) Hyojin Ko et al.   BIOORGANIC & MEDICINAL CHEMISTRY

NTPDase1 (CD39) controls nucleotide-dependent vasoconstriction in mouse

(2009) Gilles Kauffenstein et al.   CARDIOVASCULAR RESEARCH

Decreased Blood Flow with Increased Metabolic Activity: A Novel Sign of Pancreatic Tumor Aggressiveness

(2009) N. C. Nguyen et al.   CLINICAL CANCER RESEARCH

The reversible oral P2Y12 antagonist AZD6140 inhibits ADP-induced contractions in murine and human vasculature

(2009) Carl Högberg et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Quantification of Gi-Mediated Inhibition of Adenylyl Cyclase Activity Reveals That UDP Is a Potent Agonist of the Human P2Y14 Receptor

(2009) R. L. Carter et al.   MOLECULAR PHARMACOLOGY

Cyclooxygenase-2–Derived Prostaglandin F 2α Mediates Endothelium-Dependent Contractions in the Aortae of Hamsters With Increased Impact During Aging

(2008) Siu Ling Wong et al.   CIRCULATION RESEARCH

UDP Is a Competitive Antagonist at the Human P2Y14 Receptor

(2008) I. P. Fricks et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Development of selective agonists and antagonists of P2Y receptors

(2008) Kenneth A. Jacobson et al.   Purinergic Signalling

Evidence for the Expression of Multiple Uracil Nucleotide-Stimulated P2 Receptors Coupled to Smooth Muscle Contraction in Porcine Isolated Arteries

(2007) S J Rayment et al.   BRITISH JOURNAL OF PHARMACOLOGY